Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FGI-106 tetrahydrochloride demonstrates potent inhibitory activity across a broad spectrum of viruses, including those causing hemorrhagic fevers such as Ebola, Rift Valley, and Dengue Fever, with half-maximal effective concentrations (EC50s) of 100 nM, 800 nM, and 400-900 nM, respectively. Additionally, it effectively inhibits non-hemorrhagic fever viruses, notably HCV and HIV-1, with EC50s of 200 nM and 150 nM, respectively, indicating its broad-spectrum antiviral potential.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 31,000 | |||
5 mg | 在庫あり | ¥ 66,500 | |||
10 mg | 在庫あり | ¥ 104,500 | |||
25 mg | 在庫あり | ¥ 173,000 | |||
50 mg | 在庫あり | ¥ 243,500 | |||
100 mg | 在庫あり | ¥ 328,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 88,000 |
ターゲット&IC50 | EBOV:(EC50)100 nM , DENV: 400-900 nM , HIV-1:150 nM , HCV: 200 nM , Rift Valley virus: 800 nM |
分子量 | 604.48 |
分子式 | C28H42Cl4N6 |
CAS No. | 1149348-10-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 7.5 mg/ml (12.41 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FGI-106 tetrahydrochloride 1149348-10-6 Microbiology/Virology Proteases/Proteasome Virus Protease HCV Protease Influenza Virus HIV Protease fever pathogens Ebola inhibit HIV-1 replication FGI 106 Tetrahydrochloride HCV hemorrhagic Hepatitis C virus EBOV HIV tetrahydrochloride FGI106 tetrahydrochloride FGI106 Tetrahydrochloride Inhibitor FGI-106 broad-spectrum antiviral Human immunodeficiency virus FGI-106 Tetrahydrochloride lethal FGI106 FGI 106 tetrahydrochloride FGI 106 inhibitor